Životné podmienky a zdravie 2003

12. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group: The efect of vitamin E and beta
carotene on the incidence of lung cancer and other cancers in male smokers. N. Engl. J. Med., 330, 1994, s.
1029-1035.
13. Hodis, H. N., Mack, W. J., LaBrie, L. et al: Alpha-tocopherol supplementation in healthy individuals
reduces low density lipoproteion oxidation but not atherosclerosis. Circulation, 106, 2002, s. 1453 -1459.
14. Lonn, E. M., Yusuf, S., Dzavik, V. et al: Effects of ramipril and vitamin E on atherosclerosis: the study to
evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (Secure). Circulation,
103, 2001, s. 919-925.
15. Ginter, E.: Ú loha antioxidantov v prevencii kardiovaskulárnych ochorení. Bratisl. lek. Listy, 15, 1994, 5, s.
199-211.
16. Enstrom, J. E., Kanim, L. E., Klein, M. A.: Vitamin C intake and mortality among a sample of the United
States population. Epidemiology, 3, 1992, s. 194-202.
17. Ramires, J., Flowers, N. C.: Leukocyte ascorbtic acid and its relationship to coronary heart disease in man.
Am. J. Clin. Nutr., 33, 1980, s. 2079-2087.
18. Ascherio, A., Rimm, E. B., Hernan, M. A., Giovannucci, E., Kawachi, I., Stampfer, M. J., Willett, W. C.:
Relation of consumption of vitamin E, vitamin C and carotenoids to risk for stroke among men in the United
States. Ann. Intern. Med., 130, 2001, s. 1106-1114.
19. Racek, V., Holeček, J.: Kritický prístup k teorii vzniku ateroskleró zy účinkem volný ch radilálu na
lipoproteiny. Klin. Biochem. Metab., 5, 1997, s. 80-85.
20. Evans, R. W., Shaten, B. J., Day, B. W., Kuller, L. H.: Prospective association between lipid soluble
antioxidants and coronary heart disease in men: The Multiple Risk Factor Intervention Trial. Am. J.
Epidemiol., 147, 1998, s. 180-186.
21. Iribarren, C., Folsom, A. R., Jacobs Jr., D. R., Gross, M. D., Belcher, J. D., Eckfeldt, J. H.: Patterns of
covariation of serum β-carotene and α-tokoferol in middle-aged adults: The Atherosclerosis Risk in
Communities (ARIC) Study. Nutr. Metab. Cardiovasc. Dis., 7, 1997, s. 445-458.
22. Kohlmeier, L., Kark, J. D., Gomez-Garcia, E., Martin, B. C., Steck, S. E., Kardinaal, A. F., Ringstad, J.,
Thamm, M., Masaev, V., Riemmersma, R., Martin-Moreno, J. M., Huttunen, J. K., Kok, F. M.: Lycopene
and myocardial infarction risk in EURAMIC Study. Am. J. Epidemiol., 146, 1997, s. 618 -626.
23. Gey, K. F., Stähelin, H. B., Eichholzer, M.: Poor plasma status of carotene and vitamin C is associated with
higher mortality from ischemic heart disease and stroke: Basel Prospective Study. Clin. Invest., 71, 1993, s.
3-6.
24. Pietinen, P., Vartainen, E., Seppanen, R., Aro, A., Puska, P.: Changes in diet in Finland from 1972 to 1992:
impact on coronary heart disease risk. Prev. Med., 25, 1996, s. 243 -250.
25. Kok, F. J., Hofman, A.: Selenium status and cardiovascular disease: Dutch epidemiologic data. In: Selenium
in Biology and medicine, Springer Verlag, Berlin, 1989, s. 214-218.
26. Renaud, S., De Lorgeril, J. M.: Wine, alcohol, platelets and the French paradox for coronary heart disease.
Lancet, 339, 1992, s. 1523-1526.
27. de Whalley, C. V., Rankin, S. M., Hoult, J. R., Jessup, W., Leake, D. S.: Flavonoids inhibit the oxidative
modification of low density lipoproteins by macophages. Biochem. Pharmacol., 39, 1990, s. 1730 -1750.
28. Ďuračková, Z.: Antioxidanty v dobrom i zlom. Klin. Biochem. Metab., 5, 1997, s. 227-231.
29. Hertog, M. G., Feskens, E. J., Hollman, P. C., Katan, M. B., Kromhout, D.: Dietary antioxidant flavonoids
and risk of coronary heart disease: the Zutphen Elderly Study. Lancet, 342, 1996, s. 1007-1011.
30. Knekt, P., Jarvinen, R., Reunanen, A., Maatela, J.: Flavonoid intake and coronary mortality in Finland: a
cohort study. B. M. J., 312, 1996, s. 478 -481.
31. Grootveld, M., Bell, J. D., Halliwell, B., Arouma, O. I., Bonford, A, Seadler, P. J.: Non transferrin bound
iron in plasma or serum from patients with idiopathic hemochromatosis. J. Biol. Chem., 264, 1989, s. 4417-
4422.
353